Urine test identifies more than nine in ten bladder cancers, clinical study finds

New probe has recovered that much than 9 successful 10 patients with bladder crab were identified done a noninvasive urine trial aft urgent referral. The study, led by the University of Birmingham and Nonacus Ltd., progressive 964 patients crossed 7 NHS urology departments to analyse the real-world value of investigating for bladder crab utilizing a commercially disposable urine test. GALEAS™ Bladder, which tests genomic accusation from a patient's urine for traces of bladder cancer, detected 71 of 77 cancers (92.2%) among the astir 1,000 patients.